2024
DOI: 10.21203/rs.3.rs-4549530/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Study on the regulatory effect of Ligusticum chuanxiong on inflammation of human dermal papilla cells in alopecia areata based on network pharmacology and in vitro experiment

Pu Wang,
Suyue Pan,
Qiao Huang
et al.

Abstract: Ligusticum chuanxiong (CX) is a traditional Chinese medicine (TCM) for treating alopecia areata (AA). This study explored the molecular mechanism of CX active components for treating AA. In our study, we identified 13 potential targets of CX for treating AA. These targets include IL6, IL1B, IL10, IFNG, CCL2, TNF, INS, IL4, CRP, TGFB1, ALB, TP53, and BDNF.GO analysis identified 2014 meaningful items. Enriched pathways included JAK-STAT and others related to AA pathogenesis. The molecular docking results indicat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 53 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?